Project Description

DRUGS

> DRUGS LIST

Magnesium sulfate 15% (0,15g/ml) Lavoisier
Injectable solution (I.V.) in plastic ampoule

Magnesium sulfate plastic ampoule

INN : Magnesium sulfate

Primary packaging : plastic ampoule

Volume Dosage
10 ml 15 %

Pharmaceutical form
Injectable solution (IV)

PRESENTATIONS

THERAPEUTIC INDICATIONS

  • Curative treatment of torsades de pointe (TdP)
  • Treatment of acute hypokalemia associated with hypomagnesemia
  • Magnesium supplement during electrolyte rebalance
  • Magnesium supplement in parenteral nutrition
  • Preventive and curative treatment of eclampsia crisis

PHARMACEUTICAL FORM

The magnesium sulfate 15% solution is packaged in a polypropylene ampoule manufactured according to the BFS (blow fill seal) process. Its tip allows the direct connection of a syringe thanks to the luer lock system.

The bfs ampoules are available in strips of 5 units which can be individually detached from each other easily.

PHARMACO-THERAPEUTIC CLASS

Magnesium salts solution (B 05 CB) (B: Hematopoietic stem cells blood and lymphoid organs)

PHARMACODYNAMICS

Physiologically :
Magnesium is a cation primarily intracellular. It decreases neuronal excitability and neuromuscular transmission and is involved in several enzymatic reactions. Constitutional element, half of magnesium builds bone mass.

Clinically :
Serum magnesemia :

  • ranging from 12 to 17 mg/l (1 to 1.4 mEq/l or 0.5 to 0.7 mmol/l) indicates moderate magnesium deficiency,
  • under 12 mg/l (1 mEq/l or 0.5 mmol/l) indicates severe magnesium deficiency.

Magnesium deficiency may be :

  • Primary by congenital abnormality of metabolism (chronic congenital hypomagnesemia).
  • Secondary by :
    • inadequate nutritional supplements (severe denutrition, alcoholism, parenteral nutrition exclusively),
    • digestive malabsorption (chronic diarrhoea, digestive fistulas, hypoparathyroidy),
    • excessive increase of renal losses (tubulopathies, severe polyurias, diuretics abuse, chronic pyelonephritis, primary hyperaldosteronism, treatment with cisplatin).

PHARMACOKINETICS

Urinay excretion mainly.

Other forms available :

Note : warning, the therapeutic indications can change according to the dosages

PRACTICAL INFORMATION

Volume

Dosage

CIP Code

UCD Code

Box

Palett

Minimum order quantity

10 ml

15 %

3400955026600

3400894206200

Box of 100 ampoules

150 boxes (800x1200x1200)

Box of 100 ampoules

CUSTOMER SERVICE : Fax: +33 1 55 37 83 84 – @ : commercial@lavoisier.com

We invite you to read our FAQ for details on orders, complaints and commercial information.

Product available in hospitals and drugstores